Business

Mass. Movers

Growth boosts Thermo Fisher

Thermo Fisher’s drug ID scanner.

Steven Senne/AP/File

Thermo Fisher’s drug ID scanner.

Thermo Fisher Scientific Inc.’s third-quarter earnings climbed 9 percent, helped by revenue growth in key segments, and the Waltham scientific instrument and laboratory supply maker raised its forecast for 2012. The company said it earned $290.4 million, or 79 cents per share, compared to $265.4 million, or 69 cents, in last year’s quarter. Revenue grew 5 percent to $3.09 billion. The performance beat Wall Street expectations. Thermo Fisher expects adjusted 2012 earnings of $4.81 to $4.88 per share, up from its forecast $4.74 to $4.84.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com